JMIR Publications

ABSTRACT

Background:

With the rapid shift to remodel office-based dermatology into virtual clinics during the coronavirus disease-19 (Covid-19) pandemic teledermatology received an upsurge of utilization.

Objective:

To assess the patient experience with teledermatology among new versus existing clinic patients in the context of the rapid practice shift to teledermatology during the Covid-19 pandemic.

Methods:

We report a cross-sectional study of 184 teledermatology patients seen during Covid-19 at a major Southeastern medical center from May 13th to June 5th 2020. The primary outcome was patient satisfaction levels among new and existing patients. The secondary outcome was future willingness to use teledermatology.

Results:

Of 288 teledermatology patients seen during the study period, 184 (64%) completed the survey. Patients reported high overall satisfaction with teledermatology (Figure 1), with 159 (86%) participants reporting positive overall satisfaction and experience with teledermatology. New patients had significantly higher overall satisfaction with teledermatology than follow-up patients (mean Likert 4.70 for new, 4.43 for existing; p=0.03). Overall, satisfaction with teledermatology did not significantly differ by age, race/ethnicity, education level, residence, or insurance status (p>0.05). There was no significant difference in overall satisfaction by prior telehealth experience (p=0.53), video versus telephone visit type (p=0.17), or platform type (0.22). Prior telehealth experience was associated with a higher odds of willingness to use telehealth in the future (OR 2.39, 95% CI 1.31-4.35, p=0.004).

Conclusions:

This cross-sectional survey-based study reports that the rapid expansion of teledermatology was met with high levels of patient satisfaction during the Covid-19 pandemic. Further studies are needed to identify ideal disease-specific scheduling algorithms to ensure the visit modality suits the dermatologic condition being addressed. As teledermatology experiences wider adoption with the Covid-19 pandemic, it is essential to examine patient experience and satisfaction with teledermatology.